+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Drug Formulation Market Report 2026 - Product Thumbnail Image

Drug Formulation Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anthracycline Market Report 2026 - Product Thumbnail Image

Anthracycline Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Targeted Therapy Market Report 2026 - Product Thumbnail Image

Targeted Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Report 2026 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Recombinant DNA Technology Market Report 2026 - Product Thumbnail Image

Recombinant DNA Technology Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Orphan Drugs Market Report 2026 - Product Thumbnail Image

Orphan Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Histoplasmosis Treatment Market Report 2026 - Product Thumbnail Image

Histoplasmosis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Sexually Transmitted Infections (STIs) Market Report 2026 - Product Thumbnail Image

Sexually Transmitted Infections (STIs) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Small Molecule API Market Report 2026 - Product Thumbnail Image

Small Molecule API Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Urothelial Cancer Drugs Market Report 2026 - Product Thumbnail Image

Urothelial Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2026 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cancer Immunotherapy Market Report 2026 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Germ Cell Tumor Market Report 2026 - Product Thumbnail Image

Germ Cell Tumor Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Appendiceal Cancer Treatment Market Report 2026 - Product Thumbnail Image

Appendiceal Cancer Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
TNF Alpha Inhibitors Market Report 2026 - Product Thumbnail Image

TNF Alpha Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Checkpoint Inhibitors Market Report 2026 - Product Thumbnail Image

Checkpoint Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Antibody Drug Conjugates Market Report 2026 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2026 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Epigenetics Market Report 2026 - Product Thumbnail Image

Epigenetics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator